Register through Sept. 17 to receive the lowest rates for Advancing Gene + Cell Therapies for Cancer.
October 22, 2021
Dr. Kleinstiver explains how he became a genome editor, the genome editing technolgoies his lab researches, pre-CRISPR genome editing, how CRISPR and Cas9 work, and more.
Speaker: Ben Kleinstiver, PhD
Dr. Kleinstiver is a biochemist and genome editor whose interests include translating technologies into molecular medicines. He received his PhD in biochemistry from the University of Western Ontario, and completed his postdoctoral studies at Massachusetts General Hospital and Harvard Medical School.
Within the Center for Genomic Medicine at MGH, the Kleinstiver laboratory seeks to address limitations of CRISPR genome editing technologies while answering important research questions at the forefront of the genome editing field.
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico